09.09.14
Paris, France-based EOS Imaging, which makes 2-D and 3-D orthopedic medical imaging technology, has received approval from Brazilian National Health Surveillance Agency (ANVISA) to market the EOS system in Brazil. This brings the number of companies in which EOS is authorized to market its technology to 33.
Having been granted the necessary market approvals in Japan and Taiwan in October 2013 and April 2014, this additional approval is a significant milestone in the croup’s international development, company officials said.
Approval to market EOS’ imaging technology in Brazil will enable EOS to deploy its initial marketing and commercial activities in the coming months and enter a growing Latin American market, which currently represents 7 percent of the global market for medical imaging equipment.
“This marketing approval in Brazil is yet another success for our company,” said CEO Marie Meynadier. “It will enable us to begin our commercial deployment in South America, a particularly dynamic region that is eager for innovation.”
Having been granted the necessary market approvals in Japan and Taiwan in October 2013 and April 2014, this additional approval is a significant milestone in the croup’s international development, company officials said.
Approval to market EOS’ imaging technology in Brazil will enable EOS to deploy its initial marketing and commercial activities in the coming months and enter a growing Latin American market, which currently represents 7 percent of the global market for medical imaging equipment.
“This marketing approval in Brazil is yet another success for our company,” said CEO Marie Meynadier. “It will enable us to begin our commercial deployment in South America, a particularly dynamic region that is eager for innovation.”